Profile data is unavailable for this security.
About the company
Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.
- Revenue in USD (TTM)0.00
- Net income in USD-102.07m
- Incorporated2013
- Employees137.00
- LocationOdonate Inc4747 Executive Drive Ste 210SAN DIEGO 92121United StatesUSA
- Phone+1 (858) 200-3830
- Fax+1 (302) 655-5049
- Websitehttps://www.odonate.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lexaria Bioscience Corp | 404.72k | -5.44m | 37.81m | 5.00 | -- | 5.02 | -- | 93.43 | -0.6851 | -0.6851 | 0.0493 | 0.5264 | 0.0722 | -- | 1.64 | 80,944.00 | -97.62 | -95.67 | -94.18 | -96.58 | 95.66 | 76.98 | -1,351.64 | -1,612.76 | -- | -175.33 | 0.00 | -- | -11.43 | -12.19 | 8.31 | -- | -- | -- |
Fortress Biotech Inc | 85.11m | -62.86m | 39.50m | 186.00 | -- | 1.48 | -- | 0.464 | -6.65 | -6.65 | 7.96 | 1.19 | 0.3976 | 2.27 | 4.55 | 457,602.20 | -64.47 | -52.50 | -107.85 | -99.46 | 68.25 | 63.17 | -162.17 | -236.94 | 1.21 | -10.18 | 1.07 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
Qilian International Holding Group Ltd | 46.47m | -7.78m | 40.25m | 298.00 | -- | 0.9407 | -- | 0.8662 | -1.09 | -1.09 | 6.50 | 5.98 | 0.8027 | 6.45 | 33.30 | 155,944.60 | -14.03 | 2.71 | -16.84 | 3.86 | 3.77 | 11.66 | -17.48 | 2.72 | 4.43 | -0.4812 | 0.0107 | 26.11 | -28.35 | -1.60 | -822.64 | -- | 12.86 | -- |
Ocuphire Pharma Inc | 19.01m | -11.30m | 40.96m | 14.00 | -- | 0.8606 | -- | 2.15 | -0.4867 | -0.4867 | 0.8366 | 1.84 | 0.391 | -- | 4.52 | 1,357,929.00 | -23.24 | -58.31 | -25.89 | -65.94 | -- | -- | -59.44 | -137.92 | -- | -7.80 | 0.00 | -- | -52.20 | -- | -155.83 | -- | -- | -- |
Eyenovia Inc | 8.78k | -32.44m | 42.23m | 57.00 | -- | 20.03 | -- | 4,809.50 | -0.7448 | -0.7448 | 0.0002 | 0.0384 | 0.0003 | -- | 0.008 | 154.04 | -116.94 | -80.31 | -190.14 | -117.70 | 0.00 | -- | -369,519.70 | -680.95 | 0.6645 | -16.03 | 0.8914 | -- | -- | -- | 2.68 | -- | 152.20 | -- |
Incannex Healthcare Inc | -100.00bn | -100.00bn | 43.49m | -- | -- | 3.08 | -- | -- | -- | -- | -- | 0.8907 | -- | -- | -- | -- | -- | -54.94 | -- | -59.47 | -- | -- | -- | -1,033.07 | -- | -- | 0.00 | -- | 61.92 | 3.38 | -24.35 | -- | 54.12 | -- |
United-Guardian, Inc. | 11.57m | 2.75m | 44.03m | 25.00 | 16.01 | 3.94 | 15.42 | 3.81 | 0.5987 | 0.5987 | 2.52 | 2.43 | 0.926 | 3.17 | 6.40 | 462,790.80 | 22.02 | 29.84 | 25.94 | 34.39 | 48.64 | 55.31 | 23.78 | 28.79 | 5.99 | -- | 0.00 | 97.37 | -14.28 | -4.14 | 0.4616 | -9.92 | 17.19 | -19.73 |
Bright Green Corp | 0.00 | -11.46m | 49.82m | 5.00 | -- | 4.48 | -- | -- | -0.0631 | -0.0631 | 0.00 | 0.0584 | 0.00 | -- | -- | 0.00 | -56.05 | -- | -84.87 | -- | -- | -- | -- | -- | -- | -18,125.84 | 0.0289 | -- | -- | -- | 52.54 | -- | -- | -- |
Odonate Inc | 0.00 | -102.07m | 50.02m | 137.00 | -- | 1,844.41 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
Turnstone Biologics Corp | 0.00 | -74.92m | 52.04m | 82.00 | -- | 0.6504 | -- | -- | -3.53 | -3.53 | 0.00 | 3.46 | 0.00 | -- | -- | 0.00 | -80.25 | -- | -94.45 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -73.66 | -- | -78.05 | -- | -- | -- |
Rockwell Medical Inc | 86.62m | -8.42m | 53.60m | 237.00 | -- | 2.53 | -- | 0.6188 | -0.3584 | -0.3584 | 3.33 | 0.6984 | 1.90 | 13.28 | 10.12 | 365,485.20 | -18.47 | -46.29 | -27.53 | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | 1.38 | -3.54 | 0.331 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
CEL-SCI Corp | 0.00 | -29.95m | 59.58m | 43.00 | -- | 4.16 | -- | -- | -0.6304 | -0.6304 | 0.00 | 0.2645 | 0.00 | -- | -- | -- | -87.78 | -70.19 | -103.56 | -78.31 | -- | -- | -- | -15,434.15 | 1.18 | -39.26 | 0.4319 | -- | -- | -- | 13.99 | -- | 223.59 | -- |
Gritstone bio Inc | 15.65m | -144.89m | 62.04m | 231.00 | -- | 4.01 | -- | 3.97 | -1.57 | -1.57 | 0.17 | 0.1423 | 0.0901 | -- | 40.53 | 67,727.27 | -83.47 | -48.08 | -97.70 | -55.18 | -- | -- | -926.13 | -573.71 | -- | -554.88 | 0.7428 | -- | -18.05 | 68.96 | -15.71 | -- | -4.19 | -- |
Immix Biopharma Inc | 0.00 | -18.21m | 64.72m | 14.00 | -- | 2.32 | -- | -- | -0.9263 | -0.9263 | 0.00 | 1.06 | 0.00 | -- | -- | 0.00 | -77.50 | -- | -90.46 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
Data as of Jun 26 2024. Currency figures normalised to Odonate Inc's reporting currency: US Dollar USD
0.03%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
DWS Investments (UK) Ltd.as of 06 Jun 2024 | 1.00 | 0.03% |
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 0.00 | 0.00% |
BBVA Asset Management SA SGIICas of 31 Dec 2023 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.